Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.

Literature DB >> 26108808

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.

Giuseppe Boriani, Irina Savelieva, Gheorghe-Andrei Dan, Jean Claude Deharo, Charles Ferro, Carsten W Israel, Deirdre A Lane, Gaetano La Manna, Joseph Morton, Angel Moya Mitjans, Marc A Vos, Mintu P Turakhia, Gregory Y H Lip.

Abstract

Entities: Chemical

Keywords: Arrhythmias; Atrial fibrillation; Cardiac implantable electrical devices; Cardiac resynchronization therapy; Chronic kidney disease; Dialysis; Drugs; Epidemiology; Hemodialysis; Implantable cardioverter defibrillator; Infection; Pacemaker; Sudden cardiac death; Ventricular tachyarrhythmias

Mesh：

Year: 2015 PMID： 26108808 PMCID： PMC6281310 DOI： 10.1093/europace/euv202

Source DB: PubMed Journal: Europace ISSN： 1099-5129 Impact factor: 5.214

× No keyword cloud information.

255 in total

1. 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors: Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal: Europace Date: 2013-06-24 Impact factor: 5.214

2. A limited renal injury may cause a permanent form of neurogenic hypertension.

Authors: S Ye; M Gamburd; P Mozayeni; M Koss; V M Campese
Journal: Am J Hypertens Date: 1998-06 Impact factor: 2.689

3. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

Authors: A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal: Europace Date: 2012-08-24 Impact factor: 5.214

4. Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors: Gary R Matzke; George R Aronoff; Arthur J Atkinson; William M Bennett; Brian S Decker; Kai-Uwe Eckardt; Thomas Golper; Darren W Grabe; Bertram Kasiske; Frieder Keller; Jan T Kielstein; Ravindra Mehta; Bruce A Mueller; Deborah A Pasko; Franz Schaefer; Domenic A Sica; Lesley A Inker; Jason G Umans; Patrick Murray
Journal: Kidney Int Date: 2011-09-14 Impact factor: 10.612

5. Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy.

Authors: Eric S Williams; Svati H Shah; Jonathan P Piccini; Albert Y Sun; Jason I Koontz; Sana M Al-Khatib; Patrick M Hranitzky
Journal: Europace Date: 2011-08-06 Impact factor: 5.214

6. Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome.

Authors: Rutger J van Bommel; Carel Jan Willem Borleffs; Claudia Ypenburg; Nina Ajmone Marsan; Victoria Delgado; Matteo Bertini; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax
Journal: Eur Heart J Date: 2010-08-07 Impact factor: 29.983

7. Body mass index and adverse events in patients with incident atrial fibrillation.

Authors: Thure Filskov Overvad; Lars Hvilsted Rasmussen; Flemming Skjøth; Kim Overvad; Gregory Y H Lip; Torben Bjerregaard Larsen
Journal: Am J Med Date: 2013-04-17 Impact factor: 4.965

8. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.

Authors: Mahboob Rahman; Sara Pressel; Barry R Davis; Chuke Nwachuku; Jackson T Wright; Paul K Whelton; Joshua Barzilay; Vecihi Batuman; John H Eckfeldt; Michael A Farber; Stanley Franklin; Mario Henriquez; Nelson Kopyt; Gail T Louis; Mohammad Saklayen; Carole Stanford; Candace Walworth; Harry Ward; Thomas Wiegmann
Journal: Ann Intern Med Date: 2006-02-07 Impact factor: 25.391

9. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.

Authors: Larry M Baddour; Andrew E Epstein; Christopher C Erickson; Bradley P Knight; Matthew E Levison; Peter B Lockhart; Frederick A Masoudi; Eric J Okum; Walter R Wilson; Lee B Beerman; Ann F Bolger; N A Mark Estes; Michael Gewitz; Jane W Newburger; Eleanor B Schron; Kathryn A Taubert
Journal: Circulation Date: 2010-01-04 Impact factor: 29.690

10. The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) randomized controlled trial: phase 1 results on dynamics of early intervention with remote monitoring.

Authors: Giuseppe Boriani; Antoine Da Costa; Renato Pietro Ricci; Aurelio Quesada; Stefano Favale; Saverio Iacopino; Francesco Romeo; Arnaldo Risi; Lorenza Mangoni di S Stefano; Xavier Navarro; Mauro Biffi; Massimo Santini; Haran Burri
Journal: J Med Internet Res Date: 2013-08-21 Impact factor: 5.428

32 in total

1. Variations in clinical management of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation according to different equations for estimating renal function : Post hoc analysis of a prospective cohort.

Authors: Vincenzo Livio Malavasi; Daniele Pettorelli; Elisa Fantecchi; Cristina Zoccali; Giuliana Laronga; Tommaso Trenti; Gregory Yoke Hong Lip; Giuseppe Boriani
Journal: Intern Emerg Med Date: 2018-05-07 Impact factor: 3.397

2. Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease.

Authors: Felix Yang; Jessica A Hellyer; Claire Than; Aditya J Ullal; Daniel W Kaiser; Paul A Heidenreich; Donald D Hoang; Wolfgang C Winkelmayer; Susan Schmitt; Susan M Frayne; Ciaran S Phibbs; Mintu P Turakhia
Journal: Heart Date: 2016-11-15 Impact factor: 5.994

Review 3. Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.

Authors: Tatjana S Potpara; Charles J Ferro; Gregory Y H Lip
Journal: Nat Rev Nephrol Date: 2018-03-26 Impact factor: 28.314

4. Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function.

Authors: Patrick H Pun; Shubin Sheng; Gillian Sanders; Adam D DeVore; Daniel Friedman; Gregg C Fonarow; Paul A Heidenreich; Clyde W Yancy; Adrian F Hernandez; Sana M Al-Khatib
Journal: Am J Cardiol Date: 2016-12-18 Impact factor: 2.778